The world’s first clinical nutraceutical program based on microalgae A breakthrough innovation in the therapeutic management of digestive cancers The... View Article
Author Archives for Adeline Chauvigné
ALGOSOURCE announces the recruitment of the first patient in the PROPERTY clinical trial for the PHYCOCARE® product and accelerates its clinical nutraceutical program to support digestive cancer therapies
10 May 2025The world’s first clinical nutraceutical program based on microalgae A breakthrough innovation in the therapeutic management of digestive cancers The... View Article
Hemarina helps to heal injuries in reconstructive surgery with HEMO2life® oxygen carrier
During his visit to France’s Percy Army Training Hospital on 28 April 2022, The French President met several soldiers who... View Article
Hemarina helps to heal injuries in reconstructive surgery with HEMO2life® oxygen carrier
10 May 2025During his visit to France’s Percy Army Training Hospital on 28 April 2022, The French President met several soldiers who... View Article
Oncology: OSE Immunotherapeutics receives 10 million euros from Boehringer Ingelheim
Initiation of the Phase 1 clinical expansion trial triggers a €10 million milestone payment from Boehringer Ingelheim to OSE Immunotherapeutics.... View Article
Oncology: OSE Immunotherapeutics receives 10 million euros from Boehringer Ingelheim
10 May 2025Initiation of the Phase 1 clinical expansion trial triggers a €10 million milestone payment from Boehringer Ingelheim to OSE Immunotherapeutics.... View Article
Defymed and GlioCure initiate a collaboration in the field of solid tumours without therapeutic options
GlioCure, a neuro-oncology drug development company based in Angers, France, and Defymed, a Strasbourg-based medical technology company, have set themselves... View Article
Defymed and GlioCure initiate a collaboration in the field of solid tumours without therapeutic options
10 May 2025GlioCure, a neuro-oncology drug development company based in Angers, France, and Defymed, a Strasbourg-based medical technology company, have set themselves... View Article
New products for KetoM+, specialized in ketogenic food
KetoM+’s medical food brand is expanding with the goal to meet the shifting demands of a discerning and ever-increasingly savvy consumer in the... View Article
New products for KetoM+, specialized in ketogenic food
10 May 2025KetoM+’s medical food brand is expanding with the goal to meet the shifting demands of a discerning and ever-increasingly savvy consumer in the... View Article
Pherecydes Pharma announces the first international approval of a compassionate treatment with its phages
The Swedish Medical Products Agency (SMPA) has given its approval to treat a compassionate case of osteoarticular infection of a... View Article
Pherecydes Pharma announces the first international approval of a compassionate treatment with its phages
10 May 2025The Swedish Medical Products Agency (SMPA) has given its approval to treat a compassionate case of osteoarticular infection of a... View Article
Valneva initiates heterologous booster trial of inactivated, COVID-19 vaccine candidate
Valneva, a specialty vaccine company, today announced the initiation of a heterologous booster trial of its inactivated whole-virus COVID-19 vaccine... View Article
Valneva initiates heterologous booster trial of inactivated, COVID-19 vaccine candidate
10 May 2025Valneva, a specialty vaccine company, today announced the initiation of a heterologous booster trial of its inactivated whole-virus COVID-19 vaccine... View Article
iSRS 2022 International Symposium on Radiopharmaceutical Sciences | A gathering of world-renowned experts in radiopharmaceutical sciences in Nantes
From 29th May to 2nd June 2022, around 400 researchers from the world over will gather at the Cité des... View Article
iSRS 2022 International Symposium on Radiopharmaceutical Sciences | A gathering of world-renowned experts in radiopharmaceutical sciences in Nantes
10 May 2025From 29th May to 2nd June 2022, around 400 researchers from the world over will gather at the Cité des... View Article
Valneva receives conditional marketing authorization from UK MHRA for its inactivated COVID-19 vaccine
Valneva, a specialty vaccine company, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom... View Article
Valneva receives conditional marketing authorization from UK MHRA for its inactivated COVID-19 vaccine
10 May 2025Valneva, a specialty vaccine company, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom... View Article
Transplantation & immunology | Parean Biotechnologies joins a European consortium funded by Horizon Europe
Parean Biotechnologies is officially partner and consortium member, of Horus Project ! This new approved 7+ Million Euros project, funded by... View Article
Transplantation & immunology | Parean Biotechnologies joins a European consortium funded by Horizon Europe
10 May 2025Parean Biotechnologies is officially partner and consortium member, of Horus Project ! This new approved 7+ Million Euros project, funded by... View Article